GlassScriptPhysician profile
Ching-Jen Chen
NPI 1740607795
$80,104.95
in general payments reported to CMS, 2019-2025
10 companies · $15K in 2025
The $15K reported for 2025 was more than what 88% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $60K · 2022: $1,930 · 2023: $1,606 · 2024: $1,898 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,800 · Travel and Lodging: $5,449 · Food and Beverage: $4,907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,800.00 |
| Travel and Lodging | $5,448.54 |
| Food and Beverage | $4,907.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $60,432.85 | 2021-2025 | Pipeline |
| Medical Device Business Services, INC. | $12,015.67 | 2025 | Spotlight |
| Microvention, INC. | $3,915.50 | 2022-2025 | Stent, Eric Retrieval Device, Web Aneurysm Embolization System |
| Imperative Care, INC | $1,668.46 | 2022-2024 | Zoom Rdl Radial Access System, 103cm, Zoom 88-T Large Distal Platform |
| Depuy Synthes Sales INC. | $1,501.38 | 2022-2025 | Embotrap, Emboguard, Trufill |
| Penumbra, INC. | $275.63 | 2022-2025 | Red 72 |
| Globus Medical, INC. | $142.89 | 2025 | Simplify Cervical Artificial Disc, Bendini, Acp |
| Stryker Corporation | $79.53 | 2024 | Surpass Evolve, Trevo, Target |
| Astrazeneca Pharmaceuticals LP | $49.69 | 2021-2022 | |
| Chiesi USA, INC. | $23.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ching-Jen Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.